Page 11 - Towards personalized therapy for metastatic prostate cancer: technical validation of [18F]fluoromethylcholine

CONTENTS
CHAPTER 1 CHAPTER 2
CHAPTER 3
CHAPTER 4 CHAPTER 4
CHAPTER 5 CHAPTER 5
CHAPTER 6 CHAPTER6
CHAPTER 7 CHAPTER 7 ADDENDUM ADDENDUM
Introduction and outline 11 Introduction and outline
Dual-phase PET/CT to differentiate [18F]fluoromethylcholine 25 uDputalk-pehinasreaPcEtTiv/eCaTntod dmifafleigrennatniattleym[18pF]hflnuodroems ientphayltciehnotlsinweith purpotsatkaeteincarenaccetrive and malignant lymph nodes in patients with pPrLosStaOtneec.a2n0c1e2r;7(10):e48430
PLoS One. 2012;7(10):e48430
[18F]fluoromethylcholine as a chemotherapy response read-out
18
i[nFp]rfolusotarotemceatnhcyelrchceollisne as a chemotherapy response read-out 45
iMnoplrIomstagteincgaBnicoelr. 2ce0l1l5s;17(3):319–327
Mol Imaging Biol. 2015;17(3):319–327
Quantification of [18F]fluoromethylcholine kinetics in patients 63
18
Qwuitahnptrifiocsatatitoencaonfc[erF]fluoromethylcholine kinetics in patients 63
JwNituhcpl rMosetda.t2e0c1a5n;5c6e(r3):365–371
J Nucl Med. 2015;56(3):365–371
Repeatability of quantitative [18F]fluoromethylcholine PET/CT 87
18 mReepaesautraebmilietnytosfinquparnostittatteivcea[ncFe]rfluoromethylcholine PET/CT 87
Mmaenasuusrcerimpteanctsceinptperdosfotartpeucbalnicaetrion in J Nucl Med
Manuscript submitted
A clinical and experimental comparison of time of flight PET/ 111 MAcRlIinaincdalPaEnTd/CeTxpseyrsitmemenstalcomparisonoftimeofflightPET/ 111 MoRlI IamnadgPinETg/BCiTols.y2s0te15m;1s7(5):714–725
Mol Imaging Biol. 2015;17(5):714–725
General discussion, synthesis and perspectives 137 General discussion, synthesis and perspectives 137 List of abbreviations 152 DLisutcohfasbubmrmevaiartyio–nNsederlandsesamenvatting 1525 ADcuktnchowsulemdmgmareyn–tsN–eDdaenrlkawndosoerdsamenvatting 16553 CAuckrrnicouwlulemdgvmitaeents – Dankwoord 1673 LCiustrroicfuplubmlicvaitaioens 1753 List of publications 175